Related Experiment Video

Updated: Jul 14, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

No significant differences in histology and response to interferon treatment in hepatitis B carriers of genotypes C

K Luo1, H He, Z Liu

  • 1Department of Infectious Diseases and Hepatology Center, Nanfang Hospital, Guangzhou, China. luokangxian@yahoo.com.cn

Journal of Viral Hepatitis
|May 16, 2007
PubMed

Insights

Hepatitis B virus (HBV) genotypes B and C, common in China, showed no significant clinical differences when sharing the same pre-C/C gene. This suggests the shared genetic region influences their similar clinical relevance and interferon-alpha treatment response.

Area of Science:

  • Hepatology
  • Virology
  • Genetics

Background:

  • Hepatitis B virus (HBV) genotypes B and C are prevalent in China.
  • HBV genotype B often recombines with the pre-C/C gene of genotype C in this region.

Purpose of the Study:

  • To investigate clinical differences between HBV genotypes B and C when they share the same pre-C/C gene.
  • To compare demographic, clinical characteristics, and interferon-alpha (IFN-alpha) treatment outcomes in patients with these HBV genotypes.

Main Methods:

  • Determined HBV genotype in HBeAg-positive patients receiving tailored IFN-alpha therapy.
  • Compared baseline clinical data (ALT, HBV-DNA, histological scores) and treatment responses between genotype B and C patients.

Main Results:

  • No significant differences were observed in ALT levels, HBV-DNA levels, or histological activity scores between genotype B and C patients.
  • End-of-treatment and sustained response rates to IFN-alpha therapy were similar for both genotypes, with no significant variations even after extended follow-up.

Conclusions:

  • HBV genotypes B and C, despite potential recombination, exhibit similar clinical characteristics and responses to IFN-alpha therapy when sharing a common pre-C/C gene.
  • The shared pre-C/C encoding region likely accounts for the comparable clinical relevance and treatment outcomes observed between these genotypes.

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...